Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

SWI/SNF mutations can lead to gain of function

Oct. 20, 2020

Aptose begins phase Ia/b study of CG-806 in AML

Oct. 19, 2020

Agios withdraws MAA for Tibsovo for relapsed or refractory AML with IDH1 mutation

Oct. 19, 2020

Epizyme presents CREBBP and KAT3B inhibitors

Oct. 19, 2020

Insilico Medicine discloses JAK inhibitors

Oct. 19, 2020

Medshine Discovery patents Ret inhibitors

Oct. 19, 2020

Bromodomain 2-selective BET inhibitors show antitumor effect in pediatric cancer models

Oct. 19, 2020

FDA accepts IND for phase I/II study of Nuvation's NUV-422 in high-grade gliomas

Oct. 16, 2020

The cross-talk of SNAI2 and Hippo pathway in breast cancer metastasis

Oct. 16, 2020

Vorinostat + sirolimus or everolimus shows encouraging activity and safety in r/r Hodgkin's lymphoma

Oct. 16, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...